Generic azithromycin is prescription azithromycin marketed without the Zithromax trade name. Approved oral generics may be pharmaceutical equivalents to corresponding branded reference products, but “generic” alone does not tell a pharmacy which strength, dosage form or quantity to dispense. This page focuses on selecting and verifying a generic product, not on purchasing the antibiotic for an unassessed illness.
FDA evaluates generic medicines using evidence about quality, pharmaceutical equivalence and bioequivalence, with therapeutic-equivalence information available through the Orange Book for applicable products. Generic oral tablets should not be confused with azithromycin oral suspension or the distinct ophthalmic AzaSite formulation. In each case the complete prescription controls the selection.
The question at pickup is whether the pharmacy has identified an appropriate FDA-approved product for the prescribed presentation. For a branded reference family see Zithromax product details; for a direct analysis of brand and generic see the Zithromax versus generic comparison.
An approved generic is not simply a product that claims to contain azithromycin. FDA-approved generic applications must meet applicable manufacturing, labeling and performance standards. Orange Book listings can help distinguish approved oral tablets and suspensions from other formulations.
An authorized generic, where one is marketed, follows a different regulatory path from a separately approved ANDA generic. Either way, the reader should identify the specific drug product and avoid broad statements that all products sharing a drug name are automatically substitutable.
| Item | What generic verification should establish | Common mistake |
|---|---|---|
| Ingredient | Azithromycin is the active medicine | Confusing it with a different macrolide |
| Form | Tablet or reconstituted oral suspension as prescribed | Equating oral liquid with tablets |
| Strength | 250 mg or 500 mg tablet, or specified mg/5 mL concentration | Treating pack total as tablet strength |
| FDA relationship | Approved reference and applicable TE evaluation | Assuming an NDC proves current stock |
Generic azithromycin tablets commonly appear as 250 mg or 500 mg products. A listed unit strength does not specify the prescribed number of tablets or the duration of treatment. Pill appearance and manufacturer may change while a pharmacist dispenses a therapeutically equivalent approved product.
A generic 250 mg listing might be presented as a multi-tablet course or ordinary tablet stock. For more precise unit-strength identification consult the 250 mg tablet guide or the 500 mg tablet guide.
Azithromycin for oral suspension is supplied as powder to be reconstituted; available concentrations include 100 mg/5 mL and 200 mg/5 mL in approved presentations. Pharmacists must match the prescribed liquid concentration and bottle quantity to the intended dispensing instructions.
A label showing “200 mg/5 mL” is not an interchangeable volume instruction for a prescription written for 100 mg/5 mL. The liquid product hub explains concentration and measuring considerations.
Search by azithromycin as active ingredient and then filter by dosage form, route, strength and the reference product. Read any available therapeutic-equivalence codes in context. Approval and a listed NDC are separate from a pharmacy’s current inventory.
A product can be approved yet unavailable at a particular store. Conversely, a website displaying a manufacturer name is not proof that the merchant has verified inventory or that the displayed item matches a valid prescription.
Many states allow substitution of qualifying generics, subject to state law and prescription instructions. The prescriber may specify a brand or particular product, and formulation differences can make an automatic substitution inappropriate.
Ask the pharmacist whether the proposed generic matches the route, dosage form, unit strength and clinically relevant instructions. Do not make a formulation change based solely on a lower online price or a similarity in drug names.
The Z-Pak name refers to a branded 250 mg package format, not the active ingredient itself. A generic pharmacy fill can sometimes contain the prescribed number of matching-strength tablets without reproducing the branded outer carton.
Use the specific Z-Pak package description if a shopping result mentions six tablets. That page addresses package identity; it does not imply that any six tablets establish a medically appropriate regimen.
Generic competition may lower prices, yet patient cost is influenced by payer contracts, pharmacy networks, quantity, dosage form and whether the prescription matches the quoted product. A brand-specific offer could occasionally change the order of prices.
For a structured quotation comparison see azithromycin price determinants. This generic guide instead addresses which product is being compared, because a low quote on a different form is not meaningful savings.
Compare the printed label with the prescription: ingredient, strength or concentration, dosage form and the pharmacy’s directions. Check the dispensing pharmacy’s contact information and ask any questions before the medicine is used.
A change in tablet appearance alone does not mean the product is unsuitable, but unexpected differences in strength, form or directions deserve immediate clarification. A licensed pharmacist can explain whether a generic substitution was performed and why.
Yes. Azithromycin is the active ingredient of Zithromax; the exact FDA-approved product and formulation still matter.
Not automatically. Route, dosage form, strength and applicable equivalence information must match the prescription.
No. A pharmacist or prescriber must verify the formulation and directions.
No. Appearance and inactive ingredients may differ within FDA requirements.
No. Approval status and real-time inventory are different.
No. Prescription requirements apply to approved oral azithromycin products.
Patient prices vary by pharmacy, plan and offer terms; compare the exact dispensed products.